Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine
Jin Xu, Zhigang Lu, Ankita Narayan, Valerie P. Le Rouzic, Mingming Xu, Amanda Hunkele, Taylor G. Brown, William F. Hoefer, Grace C. Rossi, Richard C. Rice, Arlene Martínez-Rivera, Anjali M. Rajadhyaksha, Luca Cartegni, Daniel L. Bassoni, Gavril W. Pasternak, Ying-Xian Pan
Jin Xu, Zhigang Lu, Ankita Narayan, Valerie P. Le Rouzic, Mingming Xu, Amanda Hunkele, Taylor G. Brown, William F. Hoefer, Grace C. Rossi, Richard C. Rice, Arlene Martínez-Rivera, Anjali M. Rajadhyaksha, Luca Cartegni, Daniel L. Bassoni, Gavril W. Pasternak, Ying-Xian Pan
View: Text | PDF
Research Article Neuroscience

Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine

  • Text
  • PDF
Abstract

Extensive 3′ alternative splicing of the mu opioid receptor gene OPRM1 creates multiple C-terminal splice variants. However, their behavioral relevance remains unknown. The present study generated 3 mutant mouse models with truncated C termini in 2 different mouse strains, C57BL/6J (B6) and 129/SvEv (129). One mouse truncated all C termini downstream of Oprm1 exon 3 (mE3M mice), while the other two selectively truncated C-terminal tails encoded by either exon 4 (mE4M mice) or exon 7 (mE7M mice). Studies of these mice revealed divergent roles for the C termini in morphine-induced behaviors, highlighting the importance of C-terminal variants in complex morphine actions. In mE7M-B6 mice, the exon 7–associated truncation diminished morphine tolerance and reward without altering physical dependence, whereas the exon 4–associated truncation in mE4M-B6 mice facilitated morphine tolerance and reduced morphine dependence without affecting morphine reward. mE7M-B6 mutant mice lost morphine-induced receptor desensitization in the brain stem and hypothalamus, consistent with exon 7 involvement in morphine tolerance. In cell-based studies, exon 7–associated variants shifted the bias of several mu opioids toward β-arrestin 2 over G protein activation compared with the exon 4–associated variant, suggesting an interaction of exon 7–associated C-terminal tails with β-arrestin 2 in morphine-induced desensitization and tolerance. Together, the differential effects of C-terminal truncation illustrate the pharmacological importance of OPRM1 3′ alternative splicing.

Authors

Jin Xu, Zhigang Lu, Ankita Narayan, Valerie P. Le Rouzic, Mingming Xu, Amanda Hunkele, Taylor G. Brown, William F. Hoefer, Grace C. Rossi, Richard C. Rice, Arlene Martínez-Rivera, Anjali M. Rajadhyaksha, Luca Cartegni, Daniel L. Bassoni, Gavril W. Pasternak, Ying-Xian Pan

×

Figure 1

Effect of the C-terminal truncation on morphine tolerance.

Options: View larger image (or click on image) Download as PowerPoint
Effect of the C-terminal truncation on morphine tolerance.
(A) Morphine ...
(A) Morphine tolerance in the mutant mice. Tolerance was induced and assessed as described in Methods. The number of mice used were as follows: mE3M-B6, 15 WT and 14 homozygous (Mut) in 2 independent experiments; mE4M-B6, 18 WT and 17 Mut in 2 independent experiments; mE7M-B6, 20 WT and 19 Mut in 3 independent experiments; mE3M-129,15 WT and 11 Mut in 2 independent experiments; mE4M-129, 13 WT and 13 Mut in 2 independent experiments; mE7M-129, 7 WT and 7 Mut in 1 experiment. *P < 0.05; ***P < 0.001; ****P < 0.0001, 2-way ANOVA with Bonferroni’s post hoc test. Mut, homozygous mice. (B) Morphine dose-response curve in the mutant mice. Cumulative dose-response studies were performed before (day 1) and after (day 5) morphine treatment (ED50 values and number of mice in Table 4). (C) ANT-vMO (ANT-vMO targeting intron/exon 7) study in CD-1 mice. Top: mRNA expression of Oprm1 transcripts containing exons 1–2 (mE1-2), exons 3–4 (mE3-4), and exons 3–7 (mE3-7). RNAs from the PAG dissected on day 6 (see bottom panel) were used in RT-qPCRs. All 2-(ΔCt) values are normalized with PBS group. Results are shown as the mean ± SEM of at least 3 individual samples. *P < 0.05; **P < 0.01, 1-way ANOVA with Bonferroni’s post hoc test. Bottom: morphine tolerance. Group of mice were i.c.v. injected with 10 μg of ANT-vMO (n = 18) or MIS-vMO (n = 16), or PBS (n = 19), for 4 days (days 1–4). Tolerance was induced by twice-daily morphine injection (10 mg/kg, s.c.) for 5 days (days 2–6). Morphine analgesia was tested on days 1, 4, and 6. Results are from 2 independent experiments. #P < 0.0001, compared with PBS; †P < 0.0001, compared with MIS-vMO; *P < 0.05, compared with MIS-vMO, 2-way ANOVA with Bonferroni’s post hoc test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts